-
Gland Pharma
2,826.60 1,575.00(%) -
Tata Technolog.
830.10 890.15(%) -
IFCI
103.95 101.60(%) -
HFCL
231.40 257.00(%) -
Lumino Inds
122.00 119.00(%) -
Jindal Worldwide
57.06 47.55(%) -
Netweb Technol.
5,424.00 5,810.00(%) -
Angel One
308.20 360.20(%) -
HBL Engineering
723.85 1,121.95(%) -
Multi Comm. Exc.
3,257.00 3,479.80(%) -
Adani Total Gas
620.85 859.70(%) -
Lenskart Solut.
694.75 680.95(%) -
Oberoi Realty
1,932.25 1,985.00(%) -
RBL Bank
413.50 410.45(%) -
Tejas Networks
613.50 644.75(%) -
Polycab India
8,308.55 6,660.50(%) -
Antelopus Selan
986.05 357.00(%) -
Nuvoco Vistas
353.50 477.35(%) -
One 97
1,691.50 1,732.00(%) -
Reliance Industries
1,332.30 1,611.20(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Max Healthcare Institute Ltd Healthcare
- Analjit Singh
- BSE Code : 22865.0
- ISIN : INE027H01010
-
Today’s Low
985.50 -
Today’s High
1,000.60
-
Open
997.00 -
Perv Close
994.00 -
52W Low
903.00 -
52W High
1,221.90
Key Indicators
-
P/E(TTM)
132.38
-
Mar.Cap (₹Cr.)
96,831.28
-
Div & Yield %
0.20
-
Book Value(₹)
91.84
-
Debt-Equity Ratio
0.09
-
AGM Date
03-Sep-2026
-
EPS
7.51
-
P/E Ratio
132.38
Financials Ratios
-
Debt-Equity Ratio
0.13
-
Mar.Cap (₹Cr.)
96,831.28
-
RONW (%)
13.37
-
ROCE (%)
14.96
Score Board
-
Equity (₹ in Cr.)
973.28
-
BV (₹)
91.80
-
Sales( ₹ in Cr.)
2,874.45
-
NP (in Cr.)
728.48
-
NP Var(%)
-3.0
-
Div%
20.0
-
CPS (₹)
9.00
-
EPS (₹)
7.50
-
Traded Value (₹ in Lakhs)
96,763.15
-
52 Week High
1,221.90
-
52 Week Low
903.00
-
Price BSE
994.0
-
Price NSE
995.00
-
Market Capital( in Cr.)
96,763.15
-
P/C Ratio
111.00
-
P/E Ratio
132.80
-
Price Vs.BV
7.50
-
04-Sep-2026( 09:40)
Corporate News - Max H... - <p>Max Healthcare Institute Li...
-
03-Sep-2026( 04:22)
Corporate News - Max H... - <p>Max Healthcare Institute Li...
-
13-Aug-2026( 09:39)
Corporate News - Max H... - Max Healthcare Institute Limit...
-
13-Aug-2026( 04:23)
Results - Announcements - Max H... - Max Healthcare Institute Ltd s...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2026 Mar | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 2,874.45 | 2,663.60 | 2,446.01 | 1,997.31 | 1,855.31 | 1,079.68 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 2,874.45 | 2,663.60 | 2,446.01 | 1,997.31 | 1,855.31 | 1,079.68 |
| Other Income | 301.95 | 366.54 | 271.22 | 144.17 | 128.12 | 106.51 |
| Stock Adjustments | 0.92 | 1.11 | -1.25 | 0.00 | 0.00 | 0.00 |
| Total Income | 3,177.32 | 3,031.25 | 2,715.98 | 2,141.48 | 1,983.43 | 1,186.19 |
| EXPENDITURE : | ||||||
| Raw Materials | 639.27 | 540.94 | 429.97 | 354.42 | 446.16 | 237.12 |
| Power and Fuel Cost | 26.84 | 27.85 | 26.17 | 22.81 | 20.35 | 15.49 |
| Employee Cost | 520.22 | 492.75 | 448.89 | 372.25 | 371.43 | 265.47 |
| Other Manufacturing Expenses | 641.62 | 550.54 | 486.43 | 418.87 | 365.56 | 232.62 |
| Selling and Administration Expenses | 192.72 | 184.77 | 277.32 | 232.41 | 202.34 | 152.67 |
| Miscellaneous Expenses | 53.29 | 109.85 | 14.78 | 12.46 | 6.21 | 226.08 |
| Employee Benefit Expenses | 520.22 | 492.75 | 448.89 | 372.25 | 371.43 | 265.47 |
| Less: Preoperative Expenditure | 3.53 | 1.75 | 0.84 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 2,070.43 | 1,904.95 | 1,682.72 | 1,413.22 | 1,412.05 | 1,129.45 |
| Operating Profit | 1,106.89 | 1,126.30 | 1,033.26 | 728.26 | 571.38 | 56.74 |
| Interest | 39.87 | 48.39 | 51.66 | 51.91 | 58.93 | 112.45 |
| Gross Profit | 1,067.02 | 1,077.91 | 981.60 | 676.35 | 512.45 | -55.71 |
| Depreciation | 142.90 | 131.19 | 116.64 | 113.21 | 111.96 | 90.75 |
| Profit Before Tax | 924.12 | 946.72 | 864.96 | 563.14 | 400.49 | -146.46 |
| Current Tax | 187.84 | 197.36 | 146.90 | 111.93 | 64.94 | 0.00 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 19.67 | 48.29 | 30.80 | -243.10 | 4.03 | 17.99 |
| Reported Net Profit | 716.61 | 701.07 | 687.26 | 694.31 | 331.52 | -164.45 |
| Extraordinary Items | -11.87 | -53.81 | -0.23 | 0.53 | -0.02 | -228.49 |
| Adjusted Net Profit | 728.48 | 754.88 | 687.49 | 693.78 | 331.54 | 64.04 |
| Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.22 |
| P & L Balance brought forward | 1,950.10 | 1,394.82 | 804.70 | 110.39 | -221.13 | -2.61 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 145.82 | 145.79 | 97.14 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | 2,520.89 | 1,950.10 | 1,394.82 | 804.70 | 110.39 | -157.84 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 20.00 | 15.00 | 15.00 | 10.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 2.00 | 1.50 | 1.50 | 1.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | 7.36 | 7.21 | 7.07 | 7.15 | 3.42 | -1.70 |
| Earnings Per Share(Adj)-Unit Curr | 7.36 | 7.21 | 7.07 | 7.15 | 3.42 | -1.70 |
| Book Value | 91.85 | 85.27 | 79.03 | 72.53 | 65.09 | 61.49 |
| Book Value(Adj)-Unit Curr | 91.85 | 85.27 | 79.03 | 72.53 | 65.09 | 61.49 |
